In the Australian Shepherd, published registry data place hip dysplasia prevalence in the range of roughly 6 to 8 percent of radiographed dogs, while elbow dysplasia is recorded at lower frequencies, generally under 3 percent in the same screened populations. These figures describe dogs whose owners chose to radiograph them, not the breed at large, so they should be read as a floor rather than a census. A buyer evaluating a LOF litter is therefore working with incomplete evidence, and the practical question becomes which documents reduce that uncertainty, a subject covered in French-language guidance on Australian Shepherd health screening that frames the decision around the puppy's future life rather than the colour of its coat.
What is the recorded elbow and hip dysplasia prevalence in the Australian Shepherd?
The most frequently cited figures come from the Orthopedic Foundation for Animals (OFA) and from national kennel club schemes that publish aggregate statistics. For hips, the OFA database has historically reported an abnormal rate in the Australian Shepherd of approximately 6 to 8 percent across evaluated dogs, with most abnormal ratings falling into the mild subluxation category rather than severe dysplasia. For elbows, the recorded abnormal rate is lower, commonly cited below 3 percent, and the breed is not among those with the highest published elbow burden.
Two caveats belong in the same sentence as those numbers. First, submission is voluntary in most countries, and breeders who screen tend to be the ones whose lines are already cleaner, which biases the denominator toward better dogs. Second, radiographic grading is not perfectly reproducible between readers, so a mild rating in one registry may not map exactly onto a mild rating in another. Studies of screening programme structure, such as those summarised by the British Veterinary Association and the Kennel Club, have repeatedly shown that prevalence estimates shift when participation rates change, even without any change in the underlying dogs.
For a breed like the Australian Shepherd, which is a working dog with a substantial population outside kennel club registration, the true prevalence in the whole population is unknown and probably higher than the screened subset suggests. That is not a reason to dismiss the data. It is a reason to treat a screened pedigree as one input among several.
Which health documents should a buyer of a LOF puppy ask for?
A LOF puppy, meaning a puppy registered in the French Livre des Origines Français, comes with a pedigree that confirms parentage and registration, but the pedigree alone says nothing about joint status. The documents that matter for orthopaedic risk are separate.
Ask for the hip and elbow screening results of both parents, with the registry name, the date of the radiograph, and the official grade. In France this is typically an official reading under a recognised scheme, and in imported lines it may be an OFA, BVA, or equivalent result. A certificate without a registry name and a date is not useful.
Ask also for the results of any DNA tests relevant to the breed, with laboratory and result stated per dog. For the Australian Shepherd the commonly discussed tests concern hereditary eye conditions and the MDR1 gene, and a breeder who tracks these will have paperwork rather than verbal assurances.
Ask for the screening status of the grandparents where available, and for the number of littermates of the parents that were screened. A single good result on one parent is weaker evidence than consistent results across a wider family. Finally, ask what the breeder does with an abnormal result: whether the dog is removed from the breeding programme, bred to a lower-risk partner, or bred anyway. The answer tells you more about the practice than any single certificate.
How should screening evidence weigh in choosing between two litters?
When two litters are otherwise comparable in pedigree, temperament of the parents, and rearing conditions, screening evidence should be weighed as a reduction in probability, not as a guarantee. A litter from two dogs with normal hip and elbow grades, supported by screened grandparents, carries a lower expected risk than a litter from one screened parent and one unscreened parent. That difference is real but modest at the level of an individual puppy, because joint development also depends on growth rate, diet, exercise during the growth period, and body condition.
The practical ranking is as follows. First, both parents screened with results you can read and verify. Second, at least one parent screened and the other from a line with documented screening across generations. Third, verbal claims without documents. A breeder who cannot produce a registry result is not necessarily dishonest, but the buyer has no way to distinguish a good line from an average one.
Screening evidence should also be weighed against the things it cannot measure: how the puppies are raised, whether they are socialised in a home environment, whether the breeder asks questions about your living situation, and whether the breeder is willing to be contacted years later. A litter with excellent joint papers and no follow-up culture is a different proposition from a litter with good papers and a breeder who tracks outcomes.
What the registries do not capture
Registry statistics record radiographs, not dogs. A breed with a 6 percent abnormal hip rate in the screened population may have a considerably higher rate in the unscreened population, and no published figure resolves that gap. Elbow dysplasia in particular is graded on a scale where mild changes are common and their clinical consequence is variable; a dog with a mild elbow grade may live without lameness, while a dog with a normal grade may still develop osteoarthritis later.
This is why prevalence figures should inform a decision rather than determine it. They tell you the base rate against which a particular litter should be judged. They do not tell you what will happen to the puppy you take home.
What a buyer can reasonably do before committing
Before committing to a litter, request the documents in writing and read them. Confirm the registry, the date, and the grade for each parent. Ask about the grandparents and about any siblings of the parents that were screened. Ask what happens if the puppy develops a joint problem, and get the answer in the contract rather than in conversation.
If the breeder is transparent about what is known and what is not, that transparency is itself part of the evidence. If the answers are vague, the absence of documents is the finding.
Screening reduces risk. It does not remove it, and no pedigree replaces the conditions in which a puppy grows up.